GOOD JENNIFER L 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Jun 25, 2026
Research Summary
AI-generated summary of this filing
RHYTHM (RYTM) Director Jennifer Good Exercises Options, Receives RSUs
What Happened Jennifer L. Good, a director of RHYTHM PHARMACEUTICALS, reported exercising/converting derivative securities for 4,712 shares on 2026-06-23 (transaction code M) and, on 2026-06-24, received grants of restricted stock units (RSUs) totaling 6,015 RSUs (3,691 + 2,324; transaction code A). The filing shows $0.00 price and $0 proceeds for the disposal/derivative items reported.
Key Details
- Transaction dates: 2026-06-23 (exercise/conversion of 4,712 shares); 2026-06-24 (grants of 3,691 and 2,324 RSUs).
- Prices/proceeds reported: exercise/conversion and disposal lines show $0.00 and $0 proceeds in the filing.
- Shares owned after transaction: not specified in the provided filing extract.
- Footnotes of note:
- F1: Each RSU represents a contingent right to one share.
- F2: The RSUs are fully vested and have no expiration date.
- F3: The options referenced vest fully upon the earlier of June 24, 2027 or the day before the 2027 annual meeting, subject to continued service.
- F4: The RSUs fully vest upon the earlier of June 24, 2027 or the day before the 2027 annual meeting; no expiration date.
- Filing timeliness: Reported on 2026-06-25 for transactions on 6/23–6/24 (appears timely under Form 4 reporting rules).
Context
- Transaction codes: M = exercise/conversion of derivative (options); A = award/grant (RSUs). The filing shows a disposal line for the 4,712 shares at $0.00; the form does not explain whether that reflects a net settlement, tax withholding, transfer, or other non‑cash disposition. The RSUs reported are described as fully vested per the filing.
Insider Transaction Report
Form 4
GOOD JENNIFER L
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-06-23+4,712→ 11,712 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-06-23−4,712→ 0 total→ Common Stock (4,712 underlying) - Award
Stock Option (right to buy)
[F3]2026-06-24+3,691→ 3,691 totalExercise: $107.55Exp: 2036-06-23→ Common Stock (3,691 underlying) - Award
Restricted Stock Units
[F1][F4]2026-06-24+2,324→ 2,324 total→ Common Stock (2,324 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units are fully vested. The restricted stock units have no expiration date.
- [F3]The options fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date.
- [F4]The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Jennifer L. Good|2026-06-25